BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 18756652)

  • 1. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and management of latent tuberculosis infection.
    Hauck FR; Neese BH; Panchal AS; El-Amin W
    Am Fam Physician; 2009 May; 79(10):879-86. PubMed ID: 19496388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in the 1990's: resurgence, regimens, and resources.
    Pust RE
    South Med J; 1992 Jun; 85(6):584-93. PubMed ID: 1604386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent tuberculosis infection: diagnosis and treatment].
    Bendayan D; Raz M; Kramer MR
    Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
    Am Fam Physician; 1993 Sep; 48(4):671-2. PubMed ID: 8397483
    [No Abstract]   [Full Text] [Related]  

  • 15. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.
    Ziakas PD; Mylonakis E
    Clin Infect Dis; 2009 Dec; 49(12):1883-9. PubMed ID: 19911936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis in pregnancy: screening and treatment.
    Bergeron KG; Bonebrake RG; Allen C; Gray CJ
    Curr Womens Health Rep; 2003 Aug; 3(4):303-8. PubMed ID: 12844453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of tuberculosis in HIV-infected persons.
    Cohn DL
    Infect Dis Clin North Am; 1994 Jun; 8(2):399-412. PubMed ID: 8089467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.